Vandana Singh
·
April 29, 2025
Benzinga
FDA approves Zevaskyn as the first cell-based gene therapy for RDEB wounds after strong results in pivotal and long-term studies.
read more
June 28, 2025
May 1, 2025
Bloomberg
June 14, 2025
April 26, 2025
Barchart